Skip to content

Clinical trials

Ureteral Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ureteral Neoplasms Country / region: France Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20151
20172
20182
20211
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting3
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Astellas Pharma Global Development, Inc.2
Astellas Pharma Inc1
Bristol-Myers Squibb1
Guardant Health, Inc.1
pharmaand GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ureteral Neoplasms10
Urinary Bladder Neoplasms10
Carcinoma, Transitional Cell5
Urologic Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Urethral Neoplasms4
Esophageal Neoplasms3
Neoplasm Metastasis3
Squamous Cell Carcinoma of Head and Neck3
Ovarian Neoplasms2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.